Corrigendum to "1-Thiazol-2-yl-N-3-methyl-1H-pyrozole-5-carboxylic acid derivatives as antitumor agents" [Bioorg. Med. Chem. Lett. 27 (2017) 4471-4477]
Bioorg Med Chem Lett
.
2018 Mar 1;28(5):985.
doi: 10.1016/j.bmcl.2018.01.046.
Epub 2018 Feb 9.
Authors
Alan B Cooper
1
,
Stephane Ciblat
2
,
Gerald Shipps
3
,
Jedd Levine
4
,
Matthew Kostura
4
,
Vibha Oza
4
,
Lea Constantineau-Forget
2
,
Martin Dery
2
,
Chantal Grand-Maitre
2
,
Nicolas Bruneau-Latour
2
,
Edith Bellavance
2
,
Michael Patane
5
,
Arshad Siddiqui
2
,
Michael Luther
4
Affiliations
1
Bantam Pharmaceutical, New York, NY, United States. Electronic address: acooper@bantampharma.com.
2
Paraza Pharma, Montreal, QC, Canada.
3
Shire PLC, Lexington, MA, United States.
4
Bantam Pharmaceutical, New York, NY, United States.
5
Mitobridge, Cambridge, MA, United States.
PMID:
29433931
DOI:
10.1016/j.bmcl.2018.01.046
No abstract available
Publication types
Published Erratum